145: Why GLP-1 Drugs Don’t Fix High Insulin

📢 Ask Dr. Bikman’s Digital Mind (multilingual):

📢 Dr. Bikman’s Community & Coaching Site

Topic:

GLP-1 is often described as an insulin-stimulating hormone, but in real meal settings its main role is to slow gastric emptying and reduce the need for insulin. Chronic hyperinsulinemia may progressively silence the gut’s GLP-1-producing L-cells, creating a vicious cycle in which high insulin lowers GLP-1, and low GLP-1 drives even higher insulin.

Summary:

GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time.

Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1?

Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time.

The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental.

References:

For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy realtime, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, adfree podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more

Translation Notes:

You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.)

Also, Dr. Bikman’s Digital Mind can interact with you in many languages

In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.)

Timestamps (approximate):

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

#GLP1 #InsulinResistance #Hyperinsulinemia #MetabolicHealth #GLP1Drugs #Semaglutide #Tirzepatide #BloodSugarControl #Insulin #GutHormones #LCells #Type2Diabetes #Prediabetes #GastricEmptying #AppetiteRegulation #WeightLossScience #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience

Ben’s favorite yerba mate and fiber

Exogenous ketonesA highquality option is the NSFcertified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount

Ben’s favorite mealreplacement shake(discountBEN10)